Related Experiment Video
Updated: May 20, 2025
08:33
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
11.6K
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management
Vivek P Chavda1, Rajashri Bezbaruah2,3, Nasima Ahmed2
1Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad 380009, Gujarat, India.
Cells
|March 26, 2025
Summary
Pulmonary inflammation involves cytokines, which can worsen lung diseases like asthma and fibrosis. Broad anti-inflammatory strategies may offer better therapeutic benefits than targeting single cytokines.
Area of Science:
- Pulmonary medicine
- Immunology
- Cell biology
Background:
- Pulmonary homeostasis is disrupted by environmental or endogenous factors, triggering inflammation.
- Cytokines, signaling glycoproteins, regulate immune responses and cell behavior.
- Dysregulated cytokine production exacerbates chronic inflammation and structural lung changes.
Purpose of the Study:
- To review cytokines involved in pulmonary inflammation and respiratory disease pathogenesis.
- To investigate targeted therapeutic strategies for cytokine-mediated lung inflammation.
- To evaluate the clinical effectiveness of broad-spectrum anti-inflammatory approaches.
Main Methods:
- Comprehensive literature review.
- Identification of key cytokines (interleukins, chemokines, growth factors).
- Analysis of cytokine roles in diseases like asthma, COPD, lung cancer, pneumonia, and fibrosis.
Main Results:
- Pro-inflammatory cytokines orchestrate chronic inflammation and airway remodeling.
- Exaggerated or dysregulated cytokine responses lead to maladaptive outcomes.
- Targeting specific cytokines may lack clinical benefit; broad approaches show promise.
Conclusions:
- Cytokine profiles in pulmonary diseases are diverse and therapeutic targets.
- Broad-spectrum anti-inflammatory treatments are more likely to be clinically effective.
- Understanding cytokine-mediated inflammation is crucial for developing new lung disease therapies.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
320
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
320
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
163
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
163
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.5K